Skip to content
← The Index board

Overhyped/Fading · 5.6/10

Resveratrol

Evidence E · thin evidence ▼ 6.8% momentum 🥇 First scout open
5.6/ 10

Resveratrol is a grape and Japanese knotweed stilbenoid sold for longevity and cardiovascular benefit, but Mansouri 2025 found no overall human SIRT1 effect across 11 RCTs. Real benefit is narrow: postmenopausal cognition in Thaung Zaw 2020 and modest cardiometabolic signals in selected high-risk groups. Read the full breakdown →

The prediction game

Where does Resveratrol go in 12 months?

Lock a call and say how sure you are. Right and confident earns the most; a leaderboard spot is the prize. No money, no stakes.

The Crowd’s Call

Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.

Your 12-month call on Resveratrol

New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.

Be the first scout on record for Resveratrol. Permanent credit on this page, plus points when your call resolves.

One call per intervention. It locks the moment you submit (no edits, no cancels) and resolves in 12 months. See the scout leaderboard →

Weigh In

Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.

Tried it in real life?

Which ring does it deserve?

Same as above — one verification covers all your entries here.

Related reading

Ring Overhyped/Fading Momentum 6.8% Updated Jul 20, 2026 How the Index ranks →

Verdict by Nick Urban, host of the High Performance Longevity podcast.

For education only, not medical advice. Supplements, peptides, and protocols can interact with medications and conditions. Talk to a qualified clinician before starting anything here.